Medicare and erythropoietin

N Engl J Med. 2007 Jan 4;356(1):4-6. doi: 10.1056/NEJMp068296.
No abstract available

MeSH terms

  • Epoetin Alfa
  • Erythropoietin / economics*
  • Erythropoietin / therapeutic use
  • Health Care Reform / legislation & jurisprudence
  • Health Expenditures / trends
  • Health Services Misuse / economics*
  • Health Services Misuse / legislation & jurisprudence
  • Hemoglobins
  • Humans
  • Kidney Failure, Chronic / blood
  • Kidney Failure, Chronic / economics
  • Kidney Failure, Chronic / therapy
  • Medicare / economics*
  • Medicare / legislation & jurisprudence
  • Recombinant Proteins
  • Reimbursement Mechanisms / economics
  • Reimbursement Mechanisms / legislation & jurisprudence*
  • Renal Dialysis / economics
  • United States

Substances

  • Hemoglobins
  • Recombinant Proteins
  • Erythropoietin
  • Epoetin Alfa